Remove Bioavailability Remove Development Remove Genotype Remove In-Vivo
article thumbnail

Innovative Companies Diving into The Neuro Market Ahead of 2021

The Pharma Data

Liebisch , Vigil Neuroscience is developing a pipeline of precision-based therapies to combat both rare and common neurodegenerative diseases by restoring the vigilance of microglia. It will if the following five companies, which all launched this year with Series A financing, have anything to say about it. . Vigil Neuroscience.